The first case of successful slow pathway modulation is reported in a patient with Ebstein anomaly and recurrent atrioventricular nodal re-entrant tachycardia. Typical signals were recorded during electrophysiological study at the slow pathway region between the His bundle and the coronary sinus where ablation was performed successfully. Thus, slow pathway modulation seems to be a safe procedure even in selected patients with Ebstein anomaly.
A 31 year old woman with Ebstein anomaly was admitted for recurrent tachycardia associated with dyspnoea. She was referred because of an increasing frequency of episodes, which were terminated by intravenous verapamil. She had documented episodes of supraventricular tachycardia with a heart rate of 180 beats/min without visible P waves. She presented with classic ECG characteristics of Ebstein anomaly such as right bundle branch block and right atrial hypertrophy and a normal PR interval. The tricuspid valve was greatly displaced to the ventricle (fig 1B, C) . During the electrophysiological study, an accessory pathway was excluded and programmed atrial stimulation established the presence of dual atrioventricular nodal physiology. An atrioventricular nodal re-entrant tachycardia (cycle length 380 ms) was easily inducible by single atrial extrastimuli ( fig 1A) . Slow pathway modulation (4 mm tip catheter, 50 W, 60 s) was successfully performed. The patient remained free of symptoms during the follow up of 12 months. 
DISCUSSION
The condition, which bears Ebstein's name, is characterised by an abnormality of the tricuspid valve in which the septal leaflet and often the mural (posterior) leaflet attachment are displaced from the atrioventricular ring into the right ventricular cavity towards the apex. The association of supraventricular tachycardia and Ebstein anomaly is common. Bidirectional accessory pathways and associated WolfParkinson-White syndrome have been reported to be present in about 20-30% of these patients. 1 The associated atrioventricular reciprocating tachycardia can be life threatening. Rossi and colleagues 2 reported three cases of sudden cardiac death caused by supraventricular tachycardia in patients with Ebstein anomaly. Radiofrequency ablation is widely accepted as first line treatment for atrioventricular reciprocating tachycardia in these patients. 3 To the best of our knowledge this is the first report of a successful slow pathway modulation in a patient with Ebstein anomaly and recurrent atrioventricular nodal re-entrant tachycardia.
Structural and anatomical abnormalities have been described in patients with Ebstein anomaly. Ho and colleagues 4 examined the histology of five hearts with Ebstein anomaly. In three hearts, the compact atrioventricular node was closer to the coronary sinus ostium than in normal hearts. Therefore, the triangle of Koch may be smaller in Ebstein anomaly than in normal hearts. 4 This may be why atrioventricular nodal re-entrant tachycardia has not been reported so far and is unlikely to occur in patients with Ebstein anomaly and a small triangle of Koch. In contrast to the anatomy described in the literature, we found a normal distance between the compact atrioventricular node and the coronary sinus ostium in the patient described here. Typical signals were recorded at the slow pathway region between the His bundle and the coronary sinus (fig 1D, E) where ablation was performed successfully. Thus, slow pathway modulation seems to be a safe procedure even in selected patients with Ebstein anomaly.
